When we are still embryos, proteins of the so-called “hedgehog” signaling pathway stimulate our cells to develop into different organs.
When we are adults, this pathway falls largely silent, except in certain tissues that constantly regenerate themselves, for example our skin, and the linings of our blood vessels and digestive tract.
Unfortunately, several types of cancer cells are able to reawaken this dormant pathway, causing surrounding healthy cells to produce growth factors (proteins or hormones that stimulate cell growth) that help the cancer cells proliferate and metastasize.
A potent remedy to the problem may be on its way. In a paper published in the Journal of the American Chemical Society, researchers in the laboratory of Rudi Fasan, an associate professor of chemistry at the University of Rochester, describe the development of a cyclic peptide that is able to block the activation of the pathway in live cells.
The next step will be to further optimize the peptide for increased potency, then proceed to animal trials.
The pathway is activated when a ligand (binding molecule) produced by cancer cells interacts with a receptor on the surface of healthy cells, triggering the production of growth factors. The first drug directed against this pathway was approved by the FDA in 2012, but according to Fasan, recent studies have shown that cancer cells become quickly resistant to it.
The cyclic peptide developed in Fasan’s lab blocks the ligand farther “upstream” in the pathway, utilizing a different mode of inhibition compared to the FDA-approved drug. “It is important to have different weapons against this pathway,” Fasan says, “and we have targeted a key component of it.” He adds that the compound is unlikely to develop resistance since it does not target a protein located on cancer cells.
The researchers initially designed a cyclic peptide that mimics a native protein inhibitor of the hedgehog ligand. The researchers then used bacteria to quickly produce and screen large “libraries” of variations of this peptide, from which compounds with improved activity against the cancer ligand could be isolated.
The risk, as in any chemotherapy, is that the drug candidate Fasan’s lab is developing will also inhibit the pathway in healthy skin, blood vessel, and digestive tract tissues that rely on the pathway for normal regeneration. However, the fact that a hedgehog pathway inhibitor was recently approved for use in cancer therapy holds promise that these risks are outweighed by the benefits of inhibiting cancer growth, Fasan says.
Learn more: Rochester chemists find new means to “block” cancer cell growth
The Latest on: Cancer cell growth
[google_news title=”” keyword=”cancer cell growth” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- Harry Jowsey Reveals He Has Skin Cancer, Warns Followers To Put On Sunscreenon April 27, 2024 at 4:01 pm
Television star Harry Jowsey took to TikTok Friday with stunning news: he has skin cancer. Jowsey told his followers a dermatologist found out he had a cancerous growth on his shoulder. He’s being ...
- Why are so many young people getting cancer? Everything we know from 'ageing cells' to 'antibiotics'on April 27, 2024 at 6:15 am
Early-onset cancer cases are on the rise and are forecast to continue to surge in the next decade, with people in their 40s the most at risk. As scientists work to pinpoint the exact cause, experts ha ...
- Component of keto diet plus immunotherapy may reduce prostate canceron April 27, 2024 at 5:21 am
Adding a pre-ketone supplement—a component of a high-fat, low-carb ketogenic diet—to a type of cancer therapy in a laboratory setting was highly effective for treating prostate cancer, researchers ...
- Can vitamin D help fight cancer?on April 25, 2024 at 9:45 pm
When his colleague Evangelos Giampazolias, now at the Cancer Research UK Manchester Institute, discovered that switching off the gene which provides instructions to make the aptly named vitamin ...
- Scientists Can Now See Inside a Single Cancer Cellon April 25, 2024 at 5:00 pm
A team in the UK has found a new window into cancer, thanks to a novel imaging technique that allows them to take a detailed look at the fatty cargo inside a single tumor cell. The tech could make it ...
- Blocking gene may halt growth of breast cancer cellson April 25, 2024 at 9:35 am
Shutting down a gene called PRMT5 stopped metastatic estrogen receptor-positive (ER+) breast cancer cells from growing after they acquired resistance to a standard therapy known as CDK4/6 inhibitors, ...
- Lab-made miniorgans take scientists a step closer to curing canceron April 25, 2024 at 8:34 am
In the fight to cure cancer, scientists need better models. And they might just get them — human-derived organoids — thanks to light.
- Chemo side effect caused man's eyelash growth to go haywireon April 24, 2024 at 12:58 pm
When panitumumab triggers eyelash growth, the side effect normally shows up within the first few months of a person starting treatment and goes away after the treatment stops, the report authors noted ...
- New treatment keeps late-stage cancer patients alive for up to three yearson April 24, 2024 at 7:46 am
Late-stage stomach cancer patients are being kept alive for three years with a new technique that bathes the abdomen in warm chemotherapy drugs.
- Cancer Cells Give Orderson April 23, 2024 at 7:51 am
It is] interesting work that further highlights the complex intercellular crosstalk between stromal cells in cancer,” said Giulia Biffi, a cancer biologist at the University of Cambridge who was not ...
via Google News and Bing News